QIAGEN (QGENF) - Star of Germany's Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: JakeStraw	11/6/2008 8:17:54 AM
	of 122

QIAGEN and Institute for Animal Health Enter Partnership in Bluetongue Testing biz.yahoo.com Thursday November 6, 2:06 am ET KJ VENLO, GERMANY--(MARKET WIRE)--Nov 6, 2008 -- Worldwide license agreement expands the Company's veterinary assay portfolio and aims to contain future outbreaks of the devastating viral disease Venlo, The Netherlands - November 6, 2008 - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has announced today that it has entered into a worldwide exclusive partnership with the Institute for Animal Health (IAH), a leading research and diagnostics institution for infectious diseases of farm animals. Pursuant to the agreement QIAGEN has licensed a novel molecular assay design for bluetongue, a devastating viral disease among ruminants such as sheep and cattle. The cador BTV RT-PCR Kit, which was developed by the IAH, will be launched by QIAGEN in 2009 and further expand the company's veterinary testing portfolio.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next